Texas Attorney General Ken Paxton filed a lawsuit against Epic Systems Corporation, a major electronic health records vendor, alleging unlawful monopolization of the EHR industry and deceptive practices that restrict parental access to minor children’s medical records. The privacy-related claim asserts Epic automatically hides children’s medication lists, treatment notes, and provider messages from parents when a child turns 12, violating Texas law guaranteeing parents unrestricted access to their children’s medical records. The action is part of broader efforts to ensure EHR vendors comply with Texas parental access requirements and promote market competition.
In-house legal teams should review contracts with electronic health records (EHR) vendors and health data processors to ensure they do not include terms that restrict parental access to minor children’s medical records, particularly for children aged 12 and older. Clauses related to data access rights, proxy access, and restrictions on data sharing or portability should be updated to comply with state laws requiring unrestricted parental access to minor health data. Additionally, teams should verify that vendor agreements do not include exclusionary terms that limit competition or data interoperability, as such terms may trigger antitrust and privacy scrutiny.
Entity
Epic Systems Corporation
Also known as: Epic Systems
Industry
TechnologyOfficial Press Release
https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-sues-major-medical-record-database-gatekeeping-data-and-restricting
Petition 4
https://www.texasattorneygeneral.gov/sites/default/files/images/press/Petition_4.pdf
Texas Attorney General Enforcement Page
https://www.texasattorneygeneral.gov/consumer-protection/privacy
"Epic Systems Corporation (“Epic”)"
"December 11, 2025"
"Texas"
"Tex. Health & Safety Code § 183.006"
"restrict parental access to their minor children’s medical records"
"children’s medication lists, treatment notes, and provider messages from parents"
$3.0M
Texas Attorney General Ken Paxton announced a settlement requiring Temu to protect Texans’ sensitive personal data from exposure to the Chinese Communist Party and to strengthen product-safety practices. Temu must pay Texas $3 million, comply with data-security requirements backed by a potential $8 million annual penalty, conduct annual independent product testing, and take specified action on products found to contain harmful substances.
$773.0M
Texas Attorney General Ken Paxton announced that a multistate coalition had secured an opioid settlement with Albertsons, which would require the grocery chain to pay more than $773 million nationally once final. Texas and its political subdivisions may receive up to $57.8 million for opioid abatement; the release does not identify privacy violations.
Texas Attorney General Ken Paxton sued Gerber Products Company and Nestlé USA, Inc., alleging that Gerber made deceptive safety and testing claims while its baby food contained dangerous levels of toxic heavy metals. The lawsuit asserts claims under the Texas Deceptive Trade Practices Act; the release does not report a settlement, monetary penalty, or court order.
$1.5M
The Texas Attorney General obtained a judgment holding Rubinsky Roofing LLC liable for 27 violations of the Texas Deceptive Trade Practices Act, including deceptive practices involving older consumers and payment for unnecessary or unfinished repairs. The judgment requires more than $1.5 million in civil penalties, allocates at least $500,000 to consumer restitution, and permanently bars the company and its owner from the practices at issue.
The Texas Attorney General opened an investigation into UnitedHealth Group over allegations that its insurance-benefit administration and patient-care decisions denied Texans medically necessary healthcare. The AG issued Civil Investigative Demands to collect evidence; the release announces no penalty or remedy.
$7.5M
Texas Attorney General Ken Paxton announced a $7.5 million settlement with Tris Pharmaceuticals over alleged misrepresentations about the efficacy of Dyanavel XR, an ADHD drug marketed for children. The release says the company overstated the drug’s efficacy and directed sales representatives to make misleading claims to doctors, including Medicaid providers.